Book Value per Share: CEL-SCI Corp. (CVM)

Graphic logo of CEL-SCI Corp (CVM)

The book value per share chart for CEL-SCI Corporation (CVM) on GURU.Markets illustrates capital dynamics, where 0.62 shows the current value of the metric. Biosynthesis stability is ensured by a proprietary plant in Maryland featuring redundant ventilation. The robotization of bioreactors in clean zones minimizes errors, accelerating the market launch of Multikine. Growth prospects for CEL-SCI Corporation (CVM) depend on FDA approval and a unique immune activation mechanism.

CVM (CEL-SCI Corporation) Book Value per Share history from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for CEL-SCI Corp. (CVM)

- price and consensus price forecast:
Price Chart CEL-SCI Corp|CVM - Consensus Target
- market capitalization data:
Market Capitalization CEL-SCI Corporation|CVM - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share CEL-SCI|CVM - Book Capitalization|Market Value to Book Value Ratio cel-sci.com|CVM - Total Business Assets
- debt and liquidity data:
Total Debt to Capital CEL-SCI Corporation|CVM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital CEL-SCI Corp|CVM - Company Cumulative Debt|Debt to Book Capitalization Ratio CEL-SCI Corporation|CVM - Company Long-Term Loans and Borrowings|Company Current Liabilities CEL-SCI
Fundamental company valuation:CVM cel-sci.com
Flagship merchandise of CEL-SCI Corp.

Investors utilize multiples to verify the issuer's financial stability by assessing the real value of net assets per share. Analyzing this book value assessment allows for tracking the capital dynamics of CEL-SCI Corporation (CVM), which is critically important for the biotechnology sector, where significant pricing power following the approval of Multikine and inelastic patient demand provide fundamental potential for asset value growth.

Competitor analysis

ONC: Net Assets per Single Share|HALO - Accounting Value per Share|RVMD (Revolution Medicines) - Book Value per Share|ascentage.com (AAPG) - Accounting Value per Share|CGON (CG Oncology) - Book Value per Share|Book Value per Share URGN|Net Assets per Single Share Bicara Bio BCAX|Equity per Share Personalis Genomics (PSNL)|Erasca, Inc. - Book Value per Share|Accounting Value per Share delcath.com DCTH|YMAB (Y-mAbs Therapeutics, Inc.) - Book Value per Share|AURA: Net Asset Value per Share|Net Assets per Single Share candeltx.com CADL|Accounting Value of a Share Accuray, Inc.|SLS - Accounting Value per Share|Accounting Value of a Share actuatetherapeutics.com|Book Value per Share CTOR (Citius Oncology)|Accounting Value per Share tuhurabio.com HURA|Accounting Value per Share TARA (Protara)|Fate Pharma - Book Value per Share|Net Assets per Single Share Aadi Bio (WHWK)|TCRX - Accounting Value of a Share|Book Value per Share CSBR|XBiotech (XBIT) - Net Asset Value per Share|Book Value per Share OSTX|Accounting Value per Share radiopharmtheranostics.com|Artiva Biotherapeutics, Inc. - Book Value per Share|Net Asset Value per Share ANL (adlainortye.com)|Net Assets per Single Share Veru VERU|TPST - Net Assets per Single Share|Accounting Value per Share XLO|RENB: Book Value of One Share|muraloncology.com - Net Assets per Single Share|Kairos Pharma (KAPA) - Net Assets per Share|Book Value per Share OKUR|Accounting Value per Share CytoMed|CRIS (Curis, Inc.) - Book Value per Share|Net Assets per Share apollomicsinc.com APLM|Accounting Value per Share Tharimmune, Inc.|Accounting Value of a Share Advanced Biomed Inc. ADVB|GNPX: Book Value per Share|CLDI: Accounting Value per Share|Net Assets per Single Share SBFM|XBIO (Xenetic Biosciences, Inc.) - Net Asset Value per Share|SLRX - Net Assets per Single Share|Accounting Value of a Share PPBT|AONC - Net Assets per Single Share|Share Book Value BGNE (BeiGene Ltd.)|CKPT: Net Assets per Single Share|elevationoncology.com - Net Asset Value per Share|Net Assets per Single Share iCAD Corp (ICAD)|IKNA - Accounting Value of a Share|NTBL: Book Value per Share|Book Value per Share Viracta Therapeutics, Inc.|MorphoSys Corp (MOR) - Accounting Value per Share|Book Price of a Share NAYA Biosciences Corp|AAPGV (Ascentage Pharma Group) - Book Value per Share